Bio-Rad Laboratories Share Holder Equity 2010-2024 | BIO

Bio-Rad Laboratories share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • Bio-Rad Laboratories share holder equity for the quarter ending December 31, 2024 was $6.569B, a 24.85% decline year-over-year.
  • Bio-Rad Laboratories share holder equity for 2024 was $6.569B, a 24.85% decline from 2023.
  • Bio-Rad Laboratories share holder equity for 2023 was $8.741B, a 9.09% decline from 2022.
  • Bio-Rad Laboratories share holder equity for 2022 was $9.615B, a 29.74% decline from 2021.
Bio-Rad Laboratories Annual Share Holder Equity
(Millions of US $)
2024 $6,569
2023 $8,741
2022 $9,615
2021 $13,685
2020 $9,880
2019 $5,755
2018 $4,020
2017 $2,930
2016 $2,579
2015 $2,491
2014 $2,185
2013 $2,187
2012 $2,016
2011 $1,744
2010 $1,541
2009 $1,279
Bio-Rad Laboratories Quarterly Share Holder Equity
(Millions of US $)
2024-12-31 $6,569
2024-09-30 $7,488
2024-06-30 $6,779
2024-03-31 $9,051
2023-12-31 $8,741
2023-09-30 $8,416
2023-06-30 $8,447
2023-03-31 $9,764
2022-12-31 $9,615
2022-09-30 $8,454
2022-06-30 $8,923
2022-03-31 $10,183
2021-12-31 $13,685
2021-09-30 $15,332
2021-06-30 $11,595
2021-03-31 $10,609
2020-12-31 $9,880
2020-09-30 $8,825
2020-06-30 $7,353
2020-03-31 $6,293
2019-12-31 $5,755
2019-09-30 $5,131
2019-06-30 $5,487
2019-03-31 $4,864
2018-12-31 $4,020
2018-09-30 $4,900
2018-06-30 $4,639
2018-03-31 $4,488
2017-12-31 $2,930
2017-09-30 $2,848
2017-06-30 $2,811
2017-03-31 $2,707
2016-12-31 $2,579
2016-09-30 $2,703
2016-06-30 $2,615
2016-03-31 $2,544
2015-12-31 $2,491
2015-09-30 $2,430
2015-06-30 $2,359
2015-03-31 $2,199
2014-12-31 $2,185
2014-09-30 $2,177
2014-06-30 $2,250
2014-03-31 $2,233
2013-12-31 $2,187
2013-09-30 $2,124
2013-06-30 $2,071
2013-03-31 $2,031
2012-12-31 $2,016
2012-09-30 $1,935
2012-06-30 $1,852
2012-03-31 $1,840
2011-12-31 $1,744
2011-09-30 $1,694
2011-06-30 $1,726
2011-03-31 $1,613
2010-12-31 $1,541
2010-09-30 $1,428
2010-06-30 $1,303
2010-03-31 $1,301
2009-12-31 $1,279
2009-09-30 $1,228
2009-06-30 $1,128
2009-03-31 $1,058
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.618B $2.567B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.007B 27.90
Boston Scientific (BSX) United States $155.135B 38.84
Stryker (SYK) United States $149.698B 31.30
EssilorLuxottica (ESLOY) France $129.877B 0.00
Medtronic (MDT) Ireland $110.440B 16.12
Lonza Group Ag (LZAGY) Switzerland $48.984B 0.00
Haleon (HLN) United Kingdom $48.101B 27.36
ResMed (RMD) United States $36.449B 27.38
GE HealthCare Technologies (GEHC) United States $33.384B 15.85
Agilent Technologies (A) United States $32.046B 21.17
Terumo (TRUMY) Japan $27.153B 35.27
Koninklijke Philips (PHG) Netherlands $22.822B 16.41
Insulet (PODD) United States $22.662B 88.96
Zimmer Biomet Holdings (ZBH) United States $19.138B 12.29
Baxter (BAX) United States $15.929B 11.89
Smith & Nephew SNATS (SNN) United Kingdom $12.591B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Lantheus Holdings (LNTH) United States $5.520B 13.92
Prestige Consumer Healthcare (PBH) United States $4.305B 19.23
Perrigo (PRGO) Ireland $3.614B 9.16
Haemonetics (HAE) United States $3.485B 15.18
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.459B 25.51
Envista Holdings (NVST) United States $3.066B 25.48
QuidelOrtho (QDEL) United States $2.234B 15.36
GN Store Nord (GNNDY) Denmark $2.150B 17.81
LeMaitre Vascular (LMAT) United States $1.882B 42.07
AtriCure (ATRC) United States $1.599B 0.00
Neogen (NEOG) United States $1.424B 18.22
AdaptHealth (AHCO) United States $1.220B 12.38
Kestra Medical Technologies (KMTS) United States $1.220B 0.00
Green Thumb Industries (GTBIF) United States $1.209B 27.19
BioLife Solutions (BLFS) United States $1.045B 0.00
InMode (INMD) Israel $1.023B 9.37
Phibro Animal Health (PAHC) United States $0.966B 12.35
Evolus (EOLS) United States $0.645B 0.00
CeriBell (CBLL) United States $0.636B 0.00
Curaleaf Holdings (CURLF) Canada $0.586B 0.00
Owens & Minor (OMI) United States $0.548B 4.54
Valneva SE (VALN) France $0.516B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.499B 0.00
Tilray Brands (TLRY) Canada $0.443B 0.00
Capricor Therapeutics (CAPR) United States $0.437B 0.00
Surmodics (SRDX) United States $0.401B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.95
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Aurora Cannabis (ACB) Canada $0.279B 49.60
Sanara MedTech (SMTI) United States $0.274B 0.00
Verano Holdings (VRNOF) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Cerus (CERS) United States $0.247B 0.00
Canopy Growth (CGC) Canada $0.246B 0.00
ZimVie (ZIMV) United States $0.242B 11.00
Omeros (OMER) United States $0.230B 0.00
Biote (BTMD) United States $0.220B 6.18
Brainsway (BWAY) Israel $0.188B 49.90
High Tide (HITI) Canada $0.187B 0.00
OraSure Technologies (OSUR) United States $0.184B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.51
Quanterix (QTRX) United States $0.175B 0.00
Organigram Global (OGI) Canada $0.166B 0.00
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Jin Medical (ZJYL) China $0.129B 0.00
TerrAscend (TSNDF) Canada $0.128B 0.00
Exagen (XGN) United States $0.122B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Fonar (FONR) United States $0.084B 10.83
Veru (VERU) United States $0.075B 0.00
Agape ATP (ATPC) $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.067B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Quipt Home Medical (QIPT) United States $0.065B 0.00
United Health Products (UEEC) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.038B 13.00
Rockwell Medical (RMTI) United States $0.033B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.023B 30.57
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.019B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00